A new study by Stanford Medicine has cast doubt on the ability of Pfizer’s antiviral treatment Paxlovid to alleviate symptoms of long COVID. The research,…
The development of COVID-19 vaccines has buoyed the fortunes of several pharma and biotech companies this year. Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA), and Novavax…